Artis BioSolutions ("Artis"), an advanced therapies company dedicated to integrating the specialized technologies, ...

Artis was founded to provide platforms and capabilities that drug developers require to bring next-generation medicines to patients.

Researchers have created the first living synthetic bacterium made from non-living parts by killing a bacterial cell and then ...

Technique that inserts the genome of one bacterial species into the ‘dead’ cells of another could open doors for synthetic ...

New collaboration empowers customers with sequence-perfect constructs as long as50 kb Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Ansa Biotechnologies, ...

Modern DNA synthesis platforms empower researchers to explore the molecular world, from next-generation sequencing to cell and gene therapy development. Recent technological and scientific advances ...

Integrated DNA Technologies (IDT) expanded its synthetic biology operations with the opening of a new 25,000 ft 2 site in Coralville, IA. The two-story building will be dedicated to the manufacturing ...

If it ain't broke, don't fix it," goes the old adage, which Rice University professor James Chappell completely ignored in a recent Nature ...

The value of digital data of all types has always been important, but with the growth of today’s AI models and the data centers that support them, the need for data has exploded. This is an important ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Share Expanded facility integrates Syngoi Technologies’ enzymatic DNA platform into Artis’ North American operations ...